[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Egypt Medical Bandage Market by Product (Gauze Bandage, Adhesive Bandage, Cohesive Bandages and Elastic Bandages), Application (Surgical Wounds, Traumatic and Laceration Wounds,Burns, Ulcers, Sport Injuries, and Others), and End-User (Hospital, Clinics, and Ambulatory Surgical Centers): Opportunity Analysis and Industry Forecast, 2019–2026

April 2020 | 86 pages | ID: EBF4F05E7FC5EN
Allied Market Research

US$ 2,175.00

E-mail Delivery (PDF), Online Subscription, Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Egypt medical bandages market was valued at $14.38 million in 2018 and is expected to reach $19.12 million by 2026, registering a CAGR of 3.6% from 2019 to 2026. Medical bandages are a piece of material widely being used to protect various kinds of wounds from infection contamination. These bandages are also used to keep dressings in place or to support a medical device such as dressing or a splint. These medical products are usually sterilized thoroughly before their packaging in order to prevent the growth of bacteria. These are generally made from gauze, muslin, flannel, elastic webbing, and crinoline.

The major factors contributing to the growth of the Egypt medical bandages market include surge in adoption of these bandages to support dressing and prevent bacterial contamination. The medical bandage market is anticipated to witness a fast growth due to the expansion and emergence of wound care management sector in Egypt. However, lack of awareness regarding medical hygiene and high cost of few types of medical bandages is a major factor hampering the market growth of medical bandages in Egypt. Conversely, the healthcare sector in Egypt is offering significant opportunities for the manufacturers of medical bandages in the long term, which is attributed to the government’s healthcare reform program.

The market is segmented based on product, application, and end user. By product, it is divided into gauze bandage, adhesive bandage, cohesive and elastic bandage. On the basis of application, it is categorized into surgical wounds, traumatic and laceration wounds, burns, ulcers, sport injuries, and other wounds. By end user, it is classified into hospitals, clinics, and ambulatory surgical centers.

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
KEY MARKET SEGMENTS

By Product
  • Gauze bandage
  • Adhesive bandage
  • Cohesive bandages
  • Elastic bandage
By Application
  • Surgical wounds
  • Traumatic & laceration wounds
  • Burns
  • Ulcers
  • Sport injuries
  • Other wounds
By End-User
  • Hospitals
  • Clinics
  • Ambulatory surgical centers
LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Afri Medical
  • Baxter International Inc.
  • Intermedica
  • Johnson & Johnson
  • 3M
  • Medtronic Plc
  • Pharmaplast
  • Tri M Medical
  • Gyproc Egypt
CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
  1.4.1.Secondary research
  1.4.2.Primary research
  1.4.3.Analyst Tools and Models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
  3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Market dynamics
  3.4.1.Drivers
    3.4.1.1.Surge in road accidents in Egypt
    3.4.1.2.Surge in geriatric population in Egypt
    3.4.1.3.Increase in demand for better healthcare infrastructure
  3.4.2.Restraint
    3.4.2.1.Lack of awareness among people towards medical hygiene
    3.4.2.2.Preferencefor traditional methods for wound care
  3.4.3.Opportunity
    3.4.3.1.Increase in government initiatives toward improving the healthcare sector
    3.4.3.2.Various opportunities for the medical bandage in Egypt

CHAPTER 4:EGYPT MEDICAL BANDAGES MARKET, BY PRODUCT

4.1.Overview
  4.1.1.Market size and forecast
4.2.Gauze Bandage
  4.2.1.Key market trends and opportunities
  4.2.2.Market size and forecast
4.3.Adhesive Bandage
  4.3.1.Key market trends and growth opportunities
  4.3.2.Market size and forecast
4.4.Cohesive Bandages
  4.4.1.Key market trends and opportunities
  4.4.2.Market size and forecast
4.5.Elastic Bandages
  4.5.1.Key market trends and opportunities
  4.5.2.Market size and forecast

CHAPTER 5:EGYPT MEDICAL BANDAGES MARKET, BY APPLICATION

5.1.Overview
  5.1.1.Market size and forecast
5.2.Surgical Wounds
  5.2.1.Market size and forecast
5.3.Traumatic and Laceration Wounds
  5.3.1.Market size and forecast
5.4.Burns
  5.4.1.Market size and forecast
5.5.Ulcers
  5.5.1.Market size and forecast
5.6.Sport Injuries
  5.6.1.Market size and forecast
5.7.Other Injuries
  5.7.1.Market size and forecast

CHAPTER 6:EGYPT MEDICAL BANDAGES MARKET, BY END USER

6.1.Overview
  6.1.1.Market size and forecast
6.2.Hospital
  6.2.1.Market size and forecast
6.3.Clinics
  6.3.1.Market size and forecast
6.4.Ambulatory Surgical Centers
  6.4.1.Market size and forecast

CHAPTER 7:COMPANY PROFILES

7.1.AFRI MEDICAL
  7.1.1.Company overview
  7.1.2.Company snapshot
  7.1.3.Product portfolio
7.2.BAXTER INTERNATIONAL INC.
  7.2.1.Company overview
  7.2.2.Company snapshot
  7.2.3.Operating business segments
  7.2.4.Product portfolio
  7.2.5.Business performance
7.3.INTERMEDICA
  7.3.1.Company overview
  7.3.2.Operating business segments
  7.3.3.Product portfolio
7.4.EUROMED
  7.4.1.Company overview
  7.4.2.Operating business segments
  7.4.3.Product portfolio
7.5.JOHNSON & JOHNSON
  7.5.1.Company overview
  7.5.2.Company snapshot
  7.5.3.Operating business segments
  7.5.4.Product portfolio
  7.5.5.Business performance
  7.6.3M COMPANY
  7.6.1.Company overview
  7.6.2.Company snapshot
  7.6.3.Operating business segments
  7.6.4.Product portfolio
  7.6.5.Business performance
7.7.MEDTRONIC PLC
  7.7.1.Company overview
  7.7.2.Company snapshot
  7.7.3.Operating business segments
  7.7.4.Product portfolio
  7.7.5.Business performance
7.8.PHARMAPLAST
  7.8.1.Company overview
  7.8.2.Company snapshot
  7.8.3.Operating business segments
  7.8.4.Product portfolio
7.9.TRI M MEDICAL
  7.9.1.Company overview
  7.9.2.Company snapshot
  7.9.3.Operating business segments
  7.9.4.Product portfolio

LIST OF TABLES

TABLE 01.EGYPT MEDICAL BANDAGES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02.EGYPT MEDICAL BANDAGES MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 03.EGYPT MEDICAL BANDAGES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 04.AFRI: COMPANY SNAPSHOT
TABLE 05.AFRI: PRODUCT PORTFOLIO
TABLE 06.BAXTER: COMPANY SNAPSHOT
TABLE 07.BAXTER: BUSINESS UNITS
TABLE 08.BAXTER.: PRODUCT PORTFOLIO
TABLE 09.INTERMEDICA.: COMPANY SNAPSHOT
TABLE 10.INTERMEDICA.: OPERATING SEGMENTS
TABLE 11.INTERMEDICA.: PRODUCT PORTFOLIO
TABLE 12.EURO.: COMPANY SNAPSHOT
TABLE 13.EURO.: OPERATING SEGMENTS
TABLE 14.EURO.: PRODUCT PORTFOLIO
TABLE 15.J&J: COMPANY SNAPSHOT
TABLE 16.J&J: OPERATING BUSINESS SEGMENTS
TABLE 17.J&J: PRODUCT PORTFOLIO
TABLE 18.3M: COMPANY SNAPSHOT
TABLE 19.3M: OPERATING BUSINESS SEGMENTS
TABLE 20.3M: PRODUCT PORTFOLIO
TABLE 21.MEDTRONIC: COMPANY SNAPSHOT
TABLE 22.MEDTRONIC: OPERATING SEGMENTS
TABLE 23.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 24.PHARMAPLAST: COMPANY SNAPSHOT
TABLE 25.PHARMAPLAST: OPERATING BUSINESS SEGMENTS
TABLE 26.PHARMAPLAST: PRODUCT PORTFOLIO
TABLE 27.TRI: COMPANY SNAPSHOT
TABLE 28.TRI: OPERATING SEGMENTS
TABLE 29.TRI: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.EGYPT MEDICAL BANDAGES, MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05.HIGH THREAT OF SUBSTITUTES
FIGURE 06.HIGH THREAT OF NEW ENTRANTS
FIGURE 07.LOW COMPETITIVE RIVALRY
FIGURE 08.DRIVERS, RESTRAINTS, AND OPPORTUNITIES OF EGYPT MEDICAL BANDAGES MARKET
FIGURE 09.EGYPT MEDICAL BANDAGES MARKET FOR GAUZE BANDAGES, 2018–2026 ($MILLION)
FIGURE 10.EGYPT MEDICAL BANDAGES MARKET FOR ADHESIVE BANDAGES, 2018–2026 ($MILLION)
FIGURE 11.EGYPT MEDICAL BANDAGES MARKET FOR COHESIVE BANDAGES, 2018–2026 ($MILLION)
FIGURE 12.EGYPT MEDICAL BANDAGES MARKET FOR ELASTIC BANDAGES, 2018–2026 ($MILLION)
FIGURE 13.EGYPT MEDICAL BANDAGES MARKET FOR SURGICAL WOUNDS, 2018–2026 ($MILLION)
FIGURE 14.EGYPT MEDICAL BANDAGES MARKET FOR TRAUMATIC AND LACERATION WOUNDS, 2018–2026 ($MILLION)
FIGURE 15.EGYPT MEDICAL BANDAGES MARKET FOR BURNS, 2018–2026 ($MILLION)
FIGURE 16.EGYPT MEDICAL BANDAGES MARKET FOR BURNS, 2018–2026 ($MILLION)
FIGURE 17.EGYPT MEDICAL BANDAGES MARKET FOR SPORTS INJURIES, 2018–2026 ($MILLION)
FIGURE 18.EGYPT MEDICAL BANDAGES MARKET FOR OTHER INJURIES, 2018–2026 ($MILLION)
FIGURE 19.EGYPT MEDICAL BANDAGES MARKET FOR HOSPITAL, 2018–2026 ($MILLION)
FIGURE 20.EGYPT MEDICAL BANDAGES MARKET FOR CLINICS, 2018–2026 ($MILLION)
FIGURE 21.EGYPT MEDICAL BANDAGES MARKET FOR AMBULATORY SURGICAL CENTERS, 2018–2026 ($MILLION)
FIGURE 22.NET SALES, 2016–2018 ($MILLION)
FIGURE 23.BAXTER: REVENUE SHARE BY BUSINESS UNIT, 2018 (%)
FIGURE 24.BAXTER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25.J&J: NET SALES, 2016–2018 ($MILLION)
FIGURE 26.J&J: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27.J&J: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 28.3M: NET SALES, 2016–2018 ($MILLION)
FIGURE 29.3M: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30.3M: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 31.MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 32.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33.MEDTRONIC: REVENUE SHARE BY REGION, 2018(%)


More Publications